MMP1
protein-codingmatrix metallopeptidase 1, the group of Receptor ligands|M10 matrix metallopeptidases
Gene summary
This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This secreted protease breaks down the interstitial collagens, including types I, II, and III. The gene is part of a cluster of MMP genes on chromosome 11. Mutations in this gene are associated with chronic obstructive pulmonary disease (COPD). Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
- CLG
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MMP1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002421.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 7 | 1 | 9 | ||
| missense | 77 | 11 | 1 | 89 | ||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 0 | 0 | 83 | 18 | 3 | 104 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002412.1 | 10 | MANE Select | |
| Ensembl | ENSP00000322788.6 | 10 | MANE Select | |
| RefSeq | NP_001139410.1 | 9 | Standard | |
| Ensembl | ENSP00000806847.1 | 10 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Relaxin signaling pathway - Homo sapiens (human)
- Bladder cancer - Homo sapiens (human)
- IL-17 signaling pathway - Homo sapiens (human)
- PPAR signaling pathway - Homo sapiens (human)
- Pathways in cancer - Homo sapiens (human)
Biological Process
- proteolysis
- viral process
- cytokine-mediated signaling pathway
- extracellular matrix disassembly
- extracellular matrix organization
Molecular Function
- endopeptidase activity
- metalloendopeptidase activity
- serine-type endopeptidase activity
- zinc ion binding
Cellular Component
- extracellular region
- extracellular space
- extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000315274
- Coding exons
- 10
- Length
- 8241
- Individuals with no LoFs
- 122374
- Homozygous LoFs
- 24
- Heterozygous LoFs
- 3347
- Defined
- 125745
- p
- 0.0135
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.12 | 308 | 258 | 1.20 | 0.0000134 | 3131 |
| Missense (PolyPhen) | 112 | 95.573 | 1.1719 | 1190 | ||
| Synonymous | -0.0725 | 92 | 91.1 | 1.01 | 0.00000487 | 860 |
| Loss of Function | -0.413 | 25 | 22.9 | 1.09 | 0.00000107 | 268 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0031 | 0.0031 | notable |
| Latino/Admixed American | 0.010 | 0.010 | notable |
| Ashkenazi Jewish | 0.0043 | 0.0043 | notable |
| East Asian | 0.0016 | 0.0016 | notable |
| Finnish | 0.013 | 0.013 | notable |
| European (Non-Finnish) | 0.020 | 0.020 | notable |
| South Asian | 0.0096 | 0.0095 | notable |
| Other | 0.014 | 0.014 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Cleaves collagens of types I, II, and III at one site in the helical domain. Also cleaves collagens of types VII and X (PubMed:2557822, PubMed:2153297, PubMed:1645757). In case of HIV infection, interacts and cleaves the secreted viral Tat protein, leading to a decrease in neuronal Tat's mediated neurotoxicity (PubMed:16807369). {ECO:0000269|PubMed:1645757, ECO:0000269|PubMed:16807369, ECO:0000269|PubMed:2153297, ECO:0000269|PubMed:2557822}.;
Recessive Scores
- pRec
- 0.810
Intolerance Scores
- LoFtool
- 0.907
- RVIS EVS
- 0.73
- RVIS percentile EVS
- 86.27
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.851
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |